Biogen
-$0.96 (-0.29%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Biogen and other ETFs, options, and stocks.
About BIIB
Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. It offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for the treatment of multiple sclerosis; SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM for the treatment of severe plaque psoriasis.
CEO
Michel Vounatsos
Employees
9,100
Headquarters
Cambridge, Massachusetts
Founded
1978
BIIB Key Statistics
Market Cap
59.35B
Price-Earnings Ratio
26.10
Dividend Yield
—
Average Volume
1.40M
High Today
$328.15
Low Today
$319.85
Open Price
$322.10
Volume
1.02M
52 Week High
$468.55
52 Week Low
$223.25
BIIB News
Simply Wall St18h
Biogen Inc. Insiders Increased Their Holdings
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. On the other hand, we'd be remiss not to ment
Analyst Ratings
52%
of 33 ratings
Buy
45.5%
Hold
51.5%
Sell
3%
BIIB Earnings
$4.55
$6.45
$8.36
$10.26
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
$4.55 per share
Actual
$5.68 per share
More BIIB News
Yahoo FinanceJul 22
AT&T, Crocs, Biogen top Q2 estimates, Didi shares dip as China regulatory woes persist
Myles Udland, Brian Sozzi, and Julie Hyman breakdown more Q2 earnings, which include: AT&T stock rising as the company topped estimates due to a push from wirel
BenzingaJul 22
Biogen: Q2 Earnings Insights
Shares of Biogen (NASDAQ:BIIB) fell 0.3% in pre-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share fell 44.64% over th
CNBCJul 22
Biogen's controversial Alzheimer’s drug generates $2 million in first few weeks after approval
Biogen's Alzheimer's drug, Adhulem, generated $2 million in revenue in the first few weeks of its approval, the company said Thursday in releasing its second-qu
CNBCJul 22
Stocks making the biggest moves premarket: Netgear, Unilever, Whirlpool, Crocs & more
Check out the companies making headlines before the bell Thursday:
Netgear – Netgear shares plummeted 14.2% after the computer equipment maker reported lower-t
MarketWatchJul 22
Biogen's beats on earnings, says it's also brought in $2 million in sales of Alzheimer's drug
Shares of Biogen BIIB, +0.15% gained 1.6% in premarket trading on Thursday after the company beat expectations for the second quarter and disclosed that it's al
